[Cutaneous metastasis in cervix cancer]

Area of Science:

• Oncology
• Dermatology
• Gynecologic Oncology

Background:

• Cutaneous metastases from cervical cancer are infrequently documented.
• These skin lesions can manifest years post-remission and present as nodules, papules, or telangiectasias.
• Such metastases are generally indicative of a poor prognosis.

Observation:

• A case report details a woman with cervical cancer experiencing cutaneous metastasis.
• The patient's primary cervical cancer appeared stable under treatment with bevacizumab.
• The development of skin lesions occurred in this context of apparent disease stability.

Findings:

• Cutaneous metastasis of cervical cancer can occur despite apparent stability of the primary tumor.
• Bevacizumab treatment did not prevent the manifestation of these rare skin metastases.
• The case underscores the potential for late or unusual recurrence patterns in cervical cancer.

Implications:

• This case expands the understanding of rare cervical cancer presentations.
• It suggests the need for vigilance regarding cutaneous changes, even during systemic therapy.
• Further research may explore the mechanisms behind bevacizumab-resistant cutaneous spread in cervical cancer.